Orchestra BioMed Holdings (OBIO) Other financing activities (2022 - 2026)
Orchestra BioMed Holdings' (OBIO) quarterly Other financing activities came in at $26000.0 in Q1 2026, down 71.43% year-on-year from $91000.0 in Q1 2025, and down 71.43% on a QoQ basis from $91000.0 in Q1 2025.
Orchestra BioMed Holdings (OBIO) Other financing activities (2022 - 2026) Analysis & Trends
Orchestra BioMed Holdings (OBIO) has 5 years of Other financing activities data on file, last reported at $26000.0 in Q1 2026.
- On a quarterly basis, Other financing activities fell 71.43% year-over-year to $26000.0 in Q1 2026; TTM through Mar 2026 was $26000.0, a 91.69% decrease from a year earlier, with the FY2025 full-year figure at $91000.0, down 62.08% from the prior year.
- Other financing activities for Q1 2026 stood at $26000.0, down from $91000.0 in the prior quarter.
- Over the last five years, Other financing activities for OBIO reached as high as $56.8 million in Q3 2023 and fell as low as $1000.0 in Q1 2023.
- Historically, Other financing activities has averaged $5.2 million across 5 years, with a median of $42000.0 in 2022.
- On a YoY basis, Other financing activities climbed as much as 135107.14% in 2023 and fell as far as 98.65% in 2023.
- Year by year, Other financing activities stood at $42000.0 in 2022, then surged by 135107.14% to $56.8 million in 2023, then slumped by 99.91% to $51000.0 in 2024, then jumped by 78.43% to $91000.0 in 2025, then sank by 71.43% to $26000.0 in 2026.
- Per Business Quant data, the three most recent Other financing activities figures were $26000.0 in Q1 2026, $91000.0 in Q1 2025, and $51000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Orchestra BioMed Holdings | 228.31 Mn | 143.68 Mn | 78,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26,000.00 |
| Mar 31, 2026 | 26,000.00 |
| Mar 31, 2025 | 91,000.00 |
| Mar 31, 2025 | 91,000.00 |
| Dec 31, 2024 | 51,000.00 |
| Dec 31, 2024 | 51,000.00 |
| Jun 30, 2024 | 171,000.00 |
| Jun 30, 2024 | 171,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Mar 31, 2024 | 18,000.00 |
| Sep 30, 2023 | 56.79 Mn |
| Sep 30, 2023 | 56.79 Mn |
| Jun 30, 2023 | 22,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Mar 31, 2023 | 1,000.00 |
| Sep 30, 2022 | 42,000.00 |
| Sep 30, 2022 | 42,000.00 |
| Jun 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 5,000.00 |